| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |